FMR1 and fragile X syndrome: The participants were divided into two experimental groups: a case group consisting of 70 women with the FMR1 gene premutation (identified through previous genetic testing, including PCR and/or Southern blotting), and a control group comprising 70 women with no positive family history of FXS or intellectual disability.